News

Congratulations to CeMM PI Laura de Rooij on being awarded a prestigious grant as coordinator of the new Europe-wide project HAVOC — one of just 15 consortia selected under the Transcan-3 Joint Transnational Call 2024!

Cancer remains the second leading cause of death globally, with more than 3.9 million new cases and 1.9 million deaths each year. Through this initiative, the TRANSCAN-3 network is investing €16.7 million to support research that…

An unprecedented international effort to decode how cells manage the transport of chemical substances has culminated in four groundbreaking studies published in Molecular Systems Biology. Led by Giulio Superti-Furga at CeMM and supported by an international consortium of academic and pharmaceutical partners under the European Union's Innovative Medicines Initiative, this decade-long project provides the first comprehensive functional blueprint of…

How embarrassing it can be to forget someone’s name during a social event! With this relatable anecdote, Tony Wyss-Coray, Professor of Neurology and Neurological Sciences at Stanford Medicine, opened the 18th Landsteiner Lecture on May 12, 2025. His talk, titled “Young Blood for Old Brains and the Quest to Slow Aging”, immediately captivated the audience. Wyss-Coray used the story to illustrate a universal truth: our brains inevitably decline…

A temporary bacterial infection of the skin can cause long-lasting changes in the immune system and increase allergic inflammation. This is the result of a study led by CeMM and the Medical University of Vienna, recently published in the prestigious journal Science Immunology. The findings uncover a previously unknown connection between the skin, bone marrow and lungs, offering new prospects for the development of treatment strategies for…

Pulmonary fibrosis is a severe and chronic lung disease that predominantly affects older adults. With no specific treatments currently available, lung transplantation often remains the only option to extend patients’ lives. A research team from CeMM and MedUni Vienna has now uncovered that the aging immune system plays a crucial role in the onset and progression of the disease. Their study, published in the leading journal Science Immunology,…

Who are we? Where do we come from? Where do we belong? And where are we going? Walter Pohl started the 14th S.M.A.R.T. Lecture held on 26 March at CeMM with these fundamental questions of historical research, emphasizing why history remains of utmost importance to modern societies, beyond popular preconceptions.

In his engaging lecture, he demonstrated how these questions can be approached through a fascinating combination of classical…

We are delighted to present the CeMM Research Report 2024, centered around “Equations for Life”! 

Behind every biological process and every measurement in the life sciences lies a mathematical equation. These equations help us describe, analyze, and predict—from atomic interactions to complex ecological systems. The cover of this report is the result of a unique team effort: During a CeMM outing in October 2024, our community came together to…

Congratulations to CeMM PI Georg Winter for becoming the Scientific Director Life Sciences of AITHYRA, the new Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences. His work in targeted protein degradation is not only advancing fundamental research but also paving the way for practical applications. Together with Michael Bronstein, Scientific Director AI and Anita Ender, Managing Director, the leadership…

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on inhibiting pro-inflammatory immune cells, a study led by CeMM Adjunct PI and Professor for Dermatology at the MedUni Vienna Georg Stary shows that it is possible to restore the function of certain anti-inflammatory immune cells in a targeted manner. The results, which have…

We extend our warmest congratulations to Professors and CeMM Adjunct PI's Georg Stary and Kaan Boztug on the occasion of their inaugural lectures at the Medical University of Vienna. Their remarkable contributions to medical research and their dedication to bridging fundamental science with clinical applications continue to inspire the scientific and medical communities. During the event, CeMM Scientific Director Giulio Superti-Furga and…

The United Nations General Assembly declared 11 February as the International Day of Women and Girls in Science. Every floor, every group, every profession at CeMM is represented by women. Strong individuals. Combined with a passion for science. 

#WomenInScience 

TThe Francis Crick Institute in London (the Crick, UK) and the Ruđer Bošković Institute in Zagreb (RBI, Croatia) officially joined EU-LIFE in January 2025. This new membership is part of a process of expansion that broadens the representativeness of EU-LIFE and builds on the open and collaborative spirit that drives the alliance.

CeMM members had a great time at the Vienna Science Ball 2025 - Wiener Ball der Wissenschaften! Congratulations to Oliver Lehmann and the ball organizing team for a successful #SciBall25 and a wonderful 10th Anniversary!

The Vienna Science Ball is an exceptional opportunity to mingle with our colleagues and friends from the research community, and to celebrate the importance of science. Every professional group, every association organizes its…

From 22-23 January 2025 the annual CeMM Faculty Retreat took place at Weingut Nigl in Senftenberg, Wachau. CeMM PIs and Adjunct PIs discussed how to foster greater social and scientific cohesion among faculty. In five sessions they talked about strategic collaborative programs, translational projects and institutional partnerships, postdoc program and career developments, publication output, and budget, grants and investment plans.CeMM and its…

Researchers at CeMM and the Medical University of Vienna have developed an innovative microscopy-based approach that could predict the best approved drug to treat individual rheumatoid arthritis patients using samples of their blood. Published in the Lancet group journal EBioMedicine, the study demonstrates the feasibility of precision medicine to significantly enhance treatments for rheumatoid arthritis and likely other autoimmune…